Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
in vitro cytogenicity / chromosome aberration study in mammalian cells
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1998-08-03 to 1998-08-12
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1998

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
Deviations:
no
GLP compliance:
yes
Type of assay:
in vitro mammalian chromosome aberration test

Test material

Constituent 1
Chemical structure
Reference substance name:
4,4,13,13-tetraethoxy-3,14-dioxa-8,9-dithia-4,13-disilahexadecane
EC Number:
260-350-7
EC Name:
4,4,13,13-tetraethoxy-3,14-dioxa-8,9-dithia-4,13-disilahexadecane
Cas Number:
56706-10-6
Molecular formula:
C18H42O6S2Si2
IUPAC Name:
4,4,13,13-tetraethoxy-3,14-dioxa-8,9-dithia-4,13-disilahexadecane
Constituent 2
Reference substance name:
S2
IUPAC Name:
S2

Method

Species / strain
Species / strain / cell type:
Chinese hamster lung fibroblasts (V79)
Metabolic activation:
with and without
Metabolic activation system:
Aroclor induced rat liver S9
Test concentrations with justification for top dose:
Exp 1:7.5-120 µg/ml -S9, 10-500 µg/ml +S9; exp 2: 5-80 µg/ml -S9
Vehicle / solvent:
- Vehicle(s)/solvent(s) used: DMSO
- Justification: recommended by Sponsor
Controlsopen allclose all
Untreated negative controls:
yes
Remarks:
test medium
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
ethylmethanesulphonate
Remarks:
without activation
Untreated negative controls:
yes
Remarks:
test medium
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
cyclophosphamide
Remarks:
with activation
Details on test system and experimental conditions:
METHOD OF APPLICATION: in medium

DURATION

- Exposure duration: 4 hours (with metabolic activation); 4, 18 and 28 hours (without metabolic activation)
- Expression time (cells in growth medium): 18 and 28 hours
- Fixation time (start of exposure up to fixation or harvest of cells): 18 and 28 hours

SPINDLE INHIBITOR (cytogenetic assays): Colcemid

STAIN (for cytogenetic assays): Giesma

NUMBER OF REPLICATIONS: Duplicate cultures; independent repeat experiment

NUMBER OF CELLS EVALUATED: 200 metaphases per experimental group per experiment were examined for structural chromosomal abnormalities. 1000 cells were scored to determine the mitotic index.

DETERMINATION OF CYTOTOXICITY
- Method: mitotic index

OTHER EXAMINATIONS
- Determination of polyploidy: yes
- Determination of endoreplication: no data

METABOLIC ACTIVATION:
- Aroclor induced rat liver S9 prepared from Wistar rats with 43.7 mg/ml protein.
- S9 mix included 10% S9 and cofactor solution including MgCl2, KCl, Glucose-6-phosphate and NADP. Final concentration of S9 in cultures was approximately 1%.
Evaluation criteria:
A substance was considered negative when there was no statistically significant, biologically relevant and reproducible positive response at any test point, and no concentration related statistically significant and biologically relevant increase in structural chromosomal aberrations compared with the solvent control group.
Statistics:
Frequencies of metaphases with structural aberrations of test substance and positive control groups were compared with those of the solvent control group. A Chi squared test was applied.

Results and discussion

Test resultsopen allclose all
Key result
Species / strain:
Chinese hamster lung fibroblasts (V79)
Metabolic activation:
without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Remarks:
>50 % reduction in mitotic index at 40 μg/ml
Vehicle controls validity:
valid
Positive controls validity:
valid
Key result
Species / strain:
Chinese hamster lung fibroblasts (V79)
Metabolic activation:
with
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Remarks:
>50 % reduction in mitotic index at 40 μg/ml (without metabolic activation); 100 μg/ml (with metabolic activation)
Vehicle controls validity:
valid
Positive controls validity:
valid
Additional information on results:
TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: no significant effect
- Effects of osmolality: no significant effect
- Evaporation from medium: no data
- Water solubility: no data
- Precipitation: non-interfering precipitate noted at 100 μg/ml and above.
- Other confounding effects: none

RANGE-FINDING/SCREENING STUDIES: preliminary range finding test was carried out and cytotoxicity determined: 40 μg/ml (without metabolic activation) and 100 μg/ml (with metabolic activation

COMPARISON WITH HISTORICAL CONTROL DATA: control results were within the range of historical controls

Any other information on results incl. tables

Table 1 Chromosome aberrations Experiment 1

Without metabolic activation 4 h treatment, 18 h sampling

Treatment (μg/ml)

Number of cells analysed

Mitotic Index (mean of two cultures %)

Number of cells with Aberrations

% of cells with aberrations

inc Gaps

excl Gaps

inc Gaps

excl Gaps

01

100+++

31.0

7

7

7.0

7.0

02

200

51.0

15

11

7.5

5.5

15

200

29.0

16

10

8.0

5.0

30

200

37.0

11

8

5.5

4.0

60

192++

6.5

11

9

5.7

4.7

Positive control

200

22.5

114**

110**

57.0

55.0

With metabolic activation 4 h treatment, 18 h sampling

Treatment (μg/ml)

Number of cells analysed

Mitotic Index (mean of two cultures %)

Number of cells with Aberrations

% of cells with aberrations

inc Gaps

excl Gaps

inc Gaps

excl Gaps

01

200

78.5

16

12

8.0

6.0

02

200

106.5

13

9

6.5

4.5

31.6

200

70.5

12

8

6.0

4.0

100P

200

106.0

22

16

11.0

8.0

60P

200

28.5

21

18

10.5

9.0

Positive control

200

56.0

49**

47**

24.5

23.5

With metabolic activation 4 h treatment, 28 h sampling

Treatment (μg/ml)

Number of cells analysed

Mitotic Index (mean of two cultures %)

Number of cells with Aberrations

% of cells with aberrations

inc Gaps

excl Gaps

inc Gaps

excl Gaps

01

100+++

77.0

5

7

5.0

4.0

02

200

90.5

18

15

9.0

7.5

31.6

200

75.0

8

7

4.0

3.5

100P

200

99.0

11

8

5.5

4.0

60P

200

52.5

22

19

11.0

9.5

Positive control

200

109.0

27

21

13.5

10.5

 

1Negative control with culture medium

2Negative control with solvent (DMSO)

++ maximum number of evaluable metaphases on the slides examined

+++ determined from one culture only

* p<0.05

* p <0.01

PPrecipitation Table 2 Chromosome aberrations Experiment 2

Without metabolic activation 18 h treatment, 18 h sampling

Treatment (μg/ml)

Number of cells analysed

Mitotic Index (mean of two cultures %)

Number of cells with Aberrations

% of cells with aberrations

inc Gaps

excl Gaps

inc Gaps

excl Gaps

01

89+++

46.0

5

3

5.6

3.3

02

190++

32.5

11

7

5.8

3.7

10

142++

15.0

11

7

7.7

4.9

20

153++

16.0

10

7

6.5

4.6

40

200

8.0

11

7

5.5

3.5

Positive control

108++

12.5

12.5

26**

24.0

19.4

Without metabolic activation 28 h treatment, 28 h sampling

Treatment (μg/ml)

Number of cells analysed

Mitotic Index (mean of two cultures %)

Number of cells with Aberrations

% of cells with aberrations

inc Gaps

excl Gaps

inc Gaps

excl Gaps

01

37+++

2.0

4

4

10.8

10.8

02

200

42.0

15

13

7.5

6.5

10

200

37.0

25

17

12.5

8.5

20

151++

43.5

6

4

4.0

2.6

40

88++

6.0

5

4

5.7

4.5

Positive control

158++

27.5

5.**

47**

31.6

29.7

1Negative control with culture medium

2Negative control with solvent (DMSO)

++ maximum number of evaluable metaphases on the slides examined

+++ determined from one culture only

* p<0.05

* p <0.01

Applicant's summary and conclusion

Conclusions:
S2 has been tested according to OECD 473 and in compliance with GLP. No test substance-induced structural or numerical chromosomal aberrations were observed in Chinese hamster V79 fibroblasts when tested up to cytotoxic concentrations, with and without metabolic activation. The experiment was repeated and the results confirmed. Appropriate solvent and positive controls were included and gave expected results. It is considered that the substance is negative for cytogenicity under the conditions of the test.